Sign up TODAY and try all premium features FREE for a Month!
Sign Up
Home Mf Research Sbi Healthcare Opportunities Fund Regular Plan Growth
SBI Mutual Fund

SBI Healthcare Opportunities Fund - Regular Plan - Growth

Others Solution Oriented Fund Of Funds
Fund House : SBI Mutual Fund
Overview
Returns
Portfolio
SIP Calculator
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
NAV (as on 2025-05-31)
418.07 -0.02%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
-%
Expense Ratio (Direct)
-%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-05-26 ₹1,000.00 ₹1,000.09
0.01 %
Two Week 2025-05-16 ₹1,000.00 ₹1,000.14
0.01 %
1 Month 2025-05-02 ₹1,000.00 ₹998.99
-0.10 %
Three Months 2025-03-03 ₹3,000.00 ₹3,119.11
3.97 %
Six Months 2024-12-02 ₹6,000.00 ₹6,068.17
1.14 %
One Year 2024-05-31 ₹12,000.00 ₹12,621.51
5.18 %
Three Year 2022-06-01 ₹36,000.00 ₹53,332.08
48.14 %
Five Year 2020-06-01 ₹60,000.00 ₹104,297.49
73.83 %
Ten Year 2015-06-03 ₹120,000.00 ₹303,441.12
152.87 %
Since Inception 2004-12-31 ₹249,000.00 ₹1,721,294.49
591.28 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Ltd. Healthcare Equity 12.70
Divi's Laboratories Ltd. Healthcare Equity 6.61
Max Healthcare Institute Ltd. Healthcare Equity 6.50
Cipla Ltd. Healthcare Equity 5.18
Aurobindo Pharma Ltd. Healthcare Equity 4.33
Lupin Ltd. Healthcare Equity 4.28
Aether Industries Ltd. Chemicals Equity 4.20
Jupiter Life Line Hospitals Ltd. Healthcare Equity 4.01
Gland Pharma Ltd. Healthcare Equity 3.88
Krishna Institute Of Medical Sciences Ltd. Healthcare Equity 3.60
Abbott India Ltd. Healthcare Equity 3.43
Mankind Pharma Ltd. Healthcare Equity 3.40
Torrent Pharmaceuticals Ltd. Healthcare Equity 3.19
Alkem Laboratories Ltd. Healthcare Equity 2.67
Rainbow Children's Medicare Ltd. Healthcare Equity 2.39
Ami Organics Ltd. Chemicals Equity 2.35
Akums Drugs & Pharmaceuticals Ltd. Healthcare Equity 2.18
Aster Dm Healthcare Ltd. Healthcare Equity 2.10
Zydus Lifesciences Ltd. Healthcare Equity 2.09
JB Chemicals & Pharmaceuticals Ltd. Healthcare Equity 2.07
Fortis Healthcare Ltd. Healthcare Equity 2.02
Laurus Labs Ltd. Healthcare Equity 1.87
Dr. Lal Path Labs Ltd. Healthcare Equity 1.82
Vijaya Diagnostic Centre Ltd. Healthcare Equity 1.59
Gufic Biosciences Ltd. Healthcare Equity 1.20
Suven Pharmaceuticals Ltd. Healthcare Equity 1.15
Global Health Ltd. Healthcare Equity 0.71
Emcure Pharmaceuticals Ltd. Healthcare Equity 0.26
Sanofi Consumer Healthcare India Ltd. Healthcare Equity 0.01
Lonza Group Healthcare ADR 5.63
SIP Calculator
Risk Ratios
Standard Deviation
14.57
Beta
0.88
Sharpe Ratio
0.75
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Mr. Tanmaya Desai (Over 15 years), Mr. Pradeep Kesavan (Over 18 years),
  • Expense ration regular : -
  • Expense ration direct : -
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹500.00
  • Type : others
Exit load
For exit within 15 Days from the date of allotment - 0.50%; For exit after 15 Days from the date of allotment - Nil.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?